Astal Laboratories Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Interest and Dividend Income	-	-	-	-	2.11	2.03
Total Interest Expense	12.08	7.01	0.11	-	-	-
Net Interest Income	-12.08	-7.01	-0.11	-	2.11	2.03
Other Revenue	1,387	643.56	236.61	36.07	-	-
Revenue Before Loan Losses	1,375	636.55	236.5	36.07	2.11	2.03
Revenue	1,375	636.55	236.5	36.07	2.11	2.03
Revenue Growth (YoY)	161.04%	169.15%	555.71%	1611.01%	3.80%	0.59%
Salaries & Employee Benefits	13.96	13.39	4.66	-	0.85	0.62
Cost of Services Provided	1,201	484.21	215.42	35.67	0.11	0.13
Other Operating Expenses	23.13	16.96	5.27	-	1.12	1.05
Total Operating Expenses	1,243	516.78	225.64	35.75	2.23	1.95
Operating Income	132.42	119.78	10.87	0.32	-0.12	0.08
EBT Excluding Unusual Items	132.42	119.78	10.87	0.32	-0.12	0.08
Pretax Income	132.42	119.78	10.87	0.32	-0.17	0.08
Income Tax Expense	34.68	30.52	3.02	0.16	0	0.02
Net Income	97.74	89.25	7.85	0.16	-0.17	0.06
Net Income to Common	97.74	89.25	7.85	0.16	-0.17	0.06
Net Income Growth	51.83%	1037.42%	4684.76%	-	-	-
Shares Outstanding (Basic)	10	10	5	4	4	4
Shares Outstanding (Diluted)	14	11	5	4	4	4
Shares Change (YoY)	46.42%	119.71%	27.10%	-	-	-
EPS (Basic)	9.60	9.08	1.55	0.04	-0.04	0.02
EPS (Diluted)	7.22	8.04	1.55	0.04	-0.04	0.02
EPS Growth	3.70%	417.71%	3689.19%	-	-	-
Free Cash Flow	-	-182.92	-114.96	-14.37	-2.49	-1.86
Free Cash Flow Per Share	-	-16.48	-22.76	-3.62	-0.63	-0.47
Operating Margin	9.63%	18.82%	4.59%	0.89%	-5.74%	3.99%
Profit Margin	7.11%	14.02%	3.32%	0.46%	-8.11%	2.96%
Free Cash Flow Margin	-	-28.74%	-48.61%	-39.83%	-118.03%	-91.73%
Effective Tax Rate	26.19%	25.48%	27.78%	48.75%	-	25.77%
Revenue as Reported	1,387	643.56	236.61	-	2.11	2.03

Source: S&P Global Market Intelligence. Financial Services template. Financial Sources.